Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated in vivo without a concomitant reduction in immunogenicity

Journal of Virology

Volumn 75, Issue 1, 2001, Pages 11-18

  Verardi, P H ^a   Jones, L A ^a   Aziz, F H ^a   Ahmad, S ^a   Yilma, T D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INACTIVATED VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGENICITY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN BINDING; SEQUENCE HOMOLOGY; VACCINATION; VACCINIA VIRUS; VIROGENESIS; VIRUS ATTENUATION; VIRUS INFECTION; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; FEMALE; GENE DELETION; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; RATS; RATS, INBRED F344; RECEPTORS, INTERFERON; VACCINIA VIRUS; VIRULENCE; VIRUS REPLICATION;

EID: 0034749456     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.1.11-18.2001     Document Type: Article

References (58)

1. Vaccine development. Real and imagined dangers
2. Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus
3. A soluble receptor for interleukin-1β encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infection
4. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity
5. Enhancement of a secondary antibody response to vesicular stomatitis virus 'G' protein by IFN-γ, treatment at primary immunization
6. Complications of smallpox vaccination
7. Safety of recombinant vaccinia vaccines
8. Non-essential genes in the vaccinia virus HindIII K fragment: A gene related to serine protease inhibitors and a gene related to the 37K vaccinia virus major envelope antigen
9. The neutralization of vaccine virus by immune serum: Titration by the intracerebral inoculation of mice
10. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype
11. Gamma interferon (IFN-γ) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-γ, ligand null-mutant mice
12. Vaccinia virus expression vector: Coexpression of β-galactosidase provides visual screening of recombinant virus plaques
13. Compact, synthetic, vaccinia virus early/late promoter for protein expression
14. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon a transmembrane signaling
15. Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein
16. Generation of recombinant vaccinia viruses
17. Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression
18. A vaccinia virus double recombinant expressing the F and H genes of rinderpest virus protects cattle against rinderpest and causes no pock lesions
19. Vaccinia virus recombinants expressing chimeric proteins of human immunodeficiency virus and γ interferon are attenuated for nude mice
20. Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection
21. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: Effect of prior immunization with a trivalent SIV vaccine in modified vaccines virus Ankara
22. Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family
23. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence
24. Enhanced safety and efficacy of live attenuated SIV vaccines by prevaccination with recombinant vaccines
25. Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model
26. Expression of rabies virus glycoprotein from a recombinant vaccinia virus
27. Immunodeficient mice recover from infection with vaccinia virus expressing interferon-γ
28. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins
29. Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily
30. A rapid method for screening vaccinia virus recombinants
31. The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines
32. Use of E. coli lacZ (β-galactosidase) as a reporter gene
33. Vaccinia virus recombinants: Expression of VSV genes and protective immunization of mice and cattle
34. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety
35. Myxoma virus M-T7, a secreted homolog of the interferon-γ receptor, is a critical virulence factor for the development of myxomatosis in European rabbits
36. Species specificity of ectromelia virus and vaccinia virus interferon-γ, binding proteins
37. Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV
38. The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies: A link between Jenner and Pasteur
39. Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice
40. Vaccinia virus gene B7R encodes an 18-kDa protein that is resident in the endoplasmic reticulum and affects virus virulence
41. Vaccinia virus-encoded cytokine receptor binds and neutralizes chicken interferon-γ
42. Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection
43. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease
44. The nude rat
45. Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat
46. Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors
47. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein
48. A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus
49. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity
50. Encoding of a homolog of the IFN-γ receptor by myxoma virus
51. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene
52. Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route
53. Improved M13 phage cloning vectors and host strains: Nucleotide sequences of the M13mp18 and pUC19 vectors
54. Immune responses of cattle and mice to the G glycoprotein of vesicular stomatitis virus
55. Protection of cattle against rinderpest with vaccinia virus recombinants expressing the HA or F gene
56. Vaccinia virus recombinants expressing vesicular stomatitis genes immunize mice and cattle
57. Increased antibody responses to human papillomavirus type 16 L1 protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes